Research Topics
| Maren T ScheunerSummaryAffiliation: University of California Country: USA Publications
| Collaborators |
Detail Information
Publications
Clinical application of genetic risk assessment strategies for coronary artery disease: genotypes, phenotypes, and family historyMaren T Scheuner
Department of Health Services, University of California Los Angeles School of Public Health, 650 Charles E Young Drive, South Room 31 269 Los Angeles, CA 90095 1772, USA
Prim Care 31:711-37, xi-xii. 2004..Tests to assess genetic risk for CAD are primarily biochemical analyses that measure the different pathways involved in development and progression of disease. Some of these can guide and explain responses to treatment...- Contribution of Mendelian disorders to common chronic disease: opportunities for recognition, intervention, and preventionMaren T Scheuner
Department of Health Services, UCLA School of Public Health, Los Angeles, CA 90095 1772, USA
Am J Med Genet C Semin Med Genet 125:50-65. 2004..Genetic testing is available for most disorders, which can further clarify the genetic risk, and for some, recommendations for management and prevention are available. However, evidence-based guidelines are needed... - Genetic evaluation for coronary artery diseaseMaren T Scheuner
Cedars-Sinai Medical Center, Associate Professor of Medicine, David Geffen School of Medicine, UCLA, CDC Office of Genomics and Disease Prevention, Los Angeles, California, USA
Genet Med 5:269-85. 2003..Research is needed to assess the feasibility, clinical validity, clinical utility, and ethical, legal, and social issues of an approach that uses familial risk stratification and genetic evaluation to enhance CAD prevention efforts... - Familial risk assessment for early-onset coronary heart diseaseMaren T Scheuner
RAND Corporation, Santa Monica, CA 90407-2138, USA
Genet Med 8:525-31. 2006..Several conditions associated with increased familial risk can be prevented. These results have important implications for risk assessment and risk-reducing interventions... - Expanding the definition of a positive family history for early-onset coronary heart diseaseMaren T Scheuner
Office of Genomics and Disease Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
Genet Med 8:491-501. 2006..CONCLUSIONS: Family history beyond early-onset CHD in first-degree relatives is significantly associated with prevalent CHD diagnosed at or before age 60 years... - Quantifying the health benefits of genetic tests: a clinical perspectiveMaren T Scheuner
Genet Med 8:141-2. 2006 - Family history of type 2 diabetes: a population-based screening tool for prevention?Susan Hariri
Epidemic Intelligence Service Officer, Office of Workforce and Career Development, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Genet Med 8:102-8. 2006..To evaluate the use of self-reported family medical history as a potential screening tool to identify people at-risk for diabetes... - Can family history be used as a tool for public health and preventive medicine?Paula W Yoon
Office of Genomics and Disease Prevention, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia 30341 3724, USA
Genet Med 4:304-10. 2002 - Family history: where to go from hereMaren T Scheuner
Genet Med 5:66-8. 2003 - Research priorities for evaluating family history in the prevention of common chronic diseasesPaula W Yoon
Office of Genomics and Disease Prevention, National Center for Environmental Health, Centers for Disease Control and Prevention, 4770 Buford Highway, Atlanta, GA 39341-3724, USA
Am J Prev Med 24:128-35. 2003 
Delivery of genomic medicine for common chronic adult diseases: a systematic reviewMaren T Scheuner
RAND Corporation, Santa Monica, California 90401, USA
JAMA 299:1320-34. 2008..Attempts to integrate such knowledge into clinical practice are still in the early stages, and as a result, many questions surround the current state of this translation...